A robust, particularist ethical assessment of medical tourism Z Meghani Developing World Bioethics 11 (1), 16-29, 2011 | 93 | 2011 |
The “revolving door” between regulatory agencies and industry: a problem that requires reconceptualizing objectivity Z Meghani, J Kuzma Journal of agricultural and environmental ethics 24 (6), 575-599, 2011 | 87 | 2011 |
Regulating animals with gene drive systems: lessons from the regulatory assessment of a genetically engineered mosquito Z Meghani, J Kuzma Journal of Responsible Innovation 5 (sup1), S203-S222, 2018 | 56 | 2018 |
Genetically engineered mosquitoes, Zika and other arboviruses, community engagement, costs, and patents: Ethical issues Z Meghani, C Boëte PLoS neglected tropical diseases 12 (7), e0006501, 2018 | 45 | 2018 |
Beyond risk: A more realistic risk–benefit analysis of agricultural biotechnologies I de Melo‐Martín, Z Meghani EMBO reports 9 (4), 302-306, 2008 | 43 | 2008 |
Risk assessment of genetically modified food and neoliberalism: An argument for democratizing the regulatory review protocol of the Food and Drug Administration Z Meghani Journal of agricultural and environmental ethics 27 (6), 967-989, 2014 | 30 | 2014 |
Care for the caregivers? Transnational justice and undocumented non-citizen care workers Z Meghani, L Eckenwiler IJFAB: International Journal of Feminist Approaches to Bioethics 2 (1), 77-101, 2009 | 27 | 2009 |
The US’Food and Drug Administration, normativity of risk assessment, GMOs, and American democracy Z Meghani Journal of agricultural and environmental ethics 22 (2), 125-139, 2009 | 25 | 2009 |
Values, technologies, and epistemology Z Meghani Agriculture and Human Values 25 (1), 25-34, 2008 | 20 | 2008 |
The ethics of medical tourism: From the United Kingdom to India seeking medical care Z Meghani International Journal of Health Services 43 (4), 779-800, 2013 | 17 | 2013 |
Women migrant workers: Ethical, political and legal problems Z Meghani Routledge, 2015 | 15 | 2015 |
Michael Ryan’s Writings on Medical Ethics HA Brody, Z Meghani, K Greenwald Springer Science & Business Media, 2009 | 13 | 2009 |
The US Food and Drug Administration's evaluation of the safety of animal clones: A failure to recognize the normativity of risk assessment projects Z Meghani, I de Melo-Martín Bulletin of Science, Technology & Society 29 (1), 9-17, 2009 | 12 | 2009 |
Autonomy of Nations and Indigenous Peoples and the Environmental Release of Genetically Engineered Animals with Gene Drives Z Meghani Global Policy 10 (4), 554-568, 2019 | 9 | 2019 |
The public option: A possible change in US regulatory protocol for genetically modified organisms: compromised or enhanced objectivity? J Kuzma, Z Meghani EMBO reports 10 (12), 1288-1293, 2009 | 9 | 2009 |
Genetically Engineered Animals, Drugs, and Neoliberalism: The Need for a New Biotechnology Regulatory Policy Framework Z Meghani Journal of Agricultural and Environmental Ethics 30 (6), 715-743, 2017 | 8 | 2017 |
Regulations of consumer products Z Meghani Consumer perception of product risks and benefits, 495-513, 2017 | 6 | 2017 |
Of sex, nationalities and populations: The construction of menstruation as a patho-physiology Z Meghani Menstruation: A Cultural History. Basingstoke: Palgrave Macmillan, 130-148, 2005 | 6 | 2005 |
Trapped in a Web of Immigration and Employment Laws: Female Undocumented Home Health Workers in the US 1 Z Meghani Women Migrant Workers, 53-72, 2015 | 5 | 2015 |
The Hard Sell of Genetically Engineered (GE) Mosquitoes With Gene Drives as the Solution to Malaria: Ethical, Political, Epistemic, and Epidemiological Issues in Global Health … Z Meghani The Routledge Handbook of Feminist Philosophy of Science, 435-457, 2020 | 3 | 2020 |